These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins. Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985 [TBL] [Abstract][Full Text] [Related]
5. Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics? Khoruts A Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):435-438. PubMed ID: 29667436 [No Abstract] [Full Text] [Related]
6. Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections. Gil F; Paredes-Sabja D Future Microbiol; 2016 Sep; 11():1179-89. PubMed ID: 27546386 [TBL] [Abstract][Full Text] [Related]
7. Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model. Tague AJ; Putsathit P; Hutton ML; Hammer KA; Wales SM; Knight DR; Riley TV; Lyras D; Keller PA; Pyne SG Eur J Med Chem; 2019 May; 170():203-224. PubMed ID: 30901686 [TBL] [Abstract][Full Text] [Related]
8. Update of treatment algorithms for Clostridium difficile infection. Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934 [TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile drug pipeline: challenges in discovery and development of new agents. Jarrad AM; Karoli T; Blaskovich MA; Lyras D; Cooper MA J Med Chem; 2015 Jul; 58(13):5164-85. PubMed ID: 25760275 [TBL] [Abstract][Full Text] [Related]
11. What do we know about the diagnostics, treatment and epidemiology of Clostridioides (Clostridium) difficile infection in Europe? Nagy E J Infect Chemother; 2018 Mar; 24(3):164-170. PubMed ID: 29289484 [TBL] [Abstract][Full Text] [Related]
12. Use your antibiotics wisely. Consequences to the intestinal microbiome. Cervantes J FEMS Microbiol Lett; 2016 May; 363(10):. PubMed ID: 27044298 [TBL] [Abstract][Full Text] [Related]
13. The development of live biotherapeutics against Zhang Y; Saint Fleur A; Feng H Gut Microbes; 2022; 14(1):2052698. PubMed ID: 35319337 [No Abstract] [Full Text] [Related]
17. The potential for emerging therapeutic options for Clostridium difficile infection. Mathur H; Rea MC; Cotter PD; Ross RP; Hill C Gut Microbes; 2014; 5(6):696-710. PubMed ID: 25564777 [TBL] [Abstract][Full Text] [Related]